NCT02513316
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +14 more
- Locations
-
- UCL London, United Kingdom
Clinical trial condition
Cerebral Hemorrhage
Explore clinical trials studying Cerebral Hemorrhage. Study availability and eligibility vary by location and protocol.
298 public trials
87 recruiting studies
Cerebral Hemorrhage trial results
NCT01417117
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- Rush University Medical Center Chicago, Illinois, United States
NCT01202864
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +10 more
- Locations
-
- University of Arizona Tucson, Arizona, United States
- University of Southern California Los Angeles, California, United States
- Georgetown University Washington D.C., District of Columbia, United States
- University of Miami - Biorepository Miami, Florida, United States
NCT03247049
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +13 more
- Locations
-
Not specified
NCT02176174
- Conditions
- Abdominal Aortic Aneurysm, Aneurysm, Angina Pectoris, +50 more
- Locations
-
Not specified
NCT02326571
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +8 more
- Locations
-
- Rigshospitalet, NICU Copenhagen, Denmark
Completed
Head Position in Stroke Trial (HeadPoST)
NCT02162017
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +12 more
- Locations
-
- The George Institute for Global Health Sydney, New South Wales, Australia
NCT03040128
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +9 more
- Locations
-
Not specified
NCT00426803
- Conditions
- Acquired Bleeding Disorder, Brain Diseases, Cardiovascular Diseases, +10 more
- Locations
-
- Novo Nordisk Investigational Site Melbourne, Australia
- Novo Nordisk Investigational Site Graz, Austria
- Novo Nordisk Investigational Site Antwerp, Belgium
- Novo Nordisk Investigational Site Calgary, Canada
NCT01563445
- Conditions
- Acquired Bleeding Disorder, Brain Diseases, Cardiovascular Diseases, +10 more
- Locations
-
- Novo Nordisk Investigational Site New York, United States